GlassScriptPhysician profile
Richard Cohn
NPI 1184617193
$5,630.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $1,378 · 2021: $1,803 · 2022: $1,522 · 2023: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,263.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $596.81 | 2019-2022 | |
| Esperion Therapeutics, INC. | $546.47 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $546.24 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $478.93 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $383.23 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $337.06 | 2019-2022 | |
| Amgen INC. | $274.29 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $181.62 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $160.80 | 2019-2021 | |
| Boston Scientific Corporation | $149.76 | 2020-2022 | |
| Acutus Medical, INC. | $125.64 | 2023 | |
| Astellas Pharma US INC | $122.88 | 2021 | |
| Merck Sharp & Dohme LLC | $77.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $74.74 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $72.68 | 2020-2022 | |
| Pfizer INC. | $61.80 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $44.27 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $43.79 | 2021-2022 | |
| Novo Nordisk INC | $43.61 | 2022 | |
| Bardy Diagnostics, INC. | $30.00 | 2020 | |
| Biotronik INC. | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.